← Back to Search

Education for Melanoma Prevention in Hispanics

Phase 2

Waitlist Available

Led By Aaron R Mangold

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 and older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 3 months

Awards & highlights

Study Summary

This trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms may help reduce risk of and incidence of melanoma and improve cancer survival.

Who is the study for?

This trial is for Hispanic or Latino individuals, aged 18 and older, who are patients at the Mayo Clinic with an email on file. It aims to educate them about melanoma prevention. Those not fitting this description cannot participate.Check my eligibility

What is being tested?

The study is testing an educational program designed to increase awareness and encourage behaviors that protect against melanoma, like using sunscreen, wearing sun-protective clothing, and performing self-skin examinations.See study design

What are the potential side effects?

Since this trial involves education and questionnaires rather than medical treatments or drugs, there are no direct side effects associated with participating in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Knowledge score after completing the educational module

Secondary outcome measures

Knowledge score three months after completing the educational module

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prevention (Educational training)Experimental Treatment2 Interventions

Participants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,546 Total Patients Enrolled

557 Trials studying Melanoma

193,112 Patients Enrolled for Melanoma

Mayo ClinicLead Sponsor

3,206 Previous Clinical Trials

3,766,962 Total Patients Enrolled

40 Trials studying Melanoma

2,402 Patients Enrolled for Melanoma

Aaron R MangoldPrincipal InvestigatorMayo Clinic

2 Previous Clinical Trials

24 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05388851 — Phase 2

Melanoma Research Study Groups: Prevention (Educational training)

Melanoma Clinical Trial 2023: Educational Intervention Highlights & Side Effects. Trial Name: NCT05388851 — Phase 2

Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05388851 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining openings for prospective participants in this experiment?

"The study is currently open for enrolment, as evidenced by the entry posted on clinicaltrials.gov in December of 2022 and recently updated in May of that same year."

Answered by AI

Has Educational Intervention been given the official thumbs up by the FDA?

"With only limited data attesting to its safety, our team at Power has assigned Educational Intervention a score of 2 on the scale from 1-3."

Answered by AI

How many individuals are being included in this medical experiment?

"Affirmative. The information available on clinicaltrials.gov suggests that this experiment is actively recruiting participants; it was first posted to the site on December 1st 2022 and recently updated at the end of May, 2022. This venture needs 200000 people from one centre to take part in its research endeavours."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Education for Prevention of Melanoma in Hispanic Populations

2022. "Education for Prevention of Melanoma in Hispanic Populations". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05388851.